Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 583

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The impact of medication regimen factors on adherence to chronic treatment: a review of literature

Open access
Ingersoll, Karen S., Cohen, Jessye·2008·Journal of Behavioral Medicine
DOI 10.1007/s10865-007-9147-y
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10865-007-9147-y

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 70

  1. Amico, K. R., Harman, J. J., & Johnson, B. T. (2006). Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004. Journal of Acquired Immune Deficiency Syndrome, 41(3), 285–297. · DOI · Paper page
  2. Ammassari, A. A., Starace, F., Aloisi, M. S., Trotta, M. P., Murri, R., D’Arminio Monforte, A., & Antinori, A. (2003). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 61, 723–724. · doi:10.1212/wnl.61.5.723
  3. Balint, S., & O’Donnell, R. (2007). Beyond compliance. Occupational Health & Safety (Waco, Tex.), 76(6), 104, 106–107.
  4. Bedell, S. E., Jabbout, S., Goldberg, R., Glaser, H., Gobble, S., & Young-Xu, Y., et al. (2000). Discrepancies in the use of medications: Their extent and predictors in an outpatient practice. Archives of Internal Medicine, 160, 2129–2134. · DOI · Paper page
  5. Burke, W. J., & McArthur-Miller, D. A. (2001). Exploring treatment alternatives: Weekly dosing of fluoxetine for the continuation phase of major depressive disorder. Journal of Clinical Psychiatry, 62(Suppl), 38–42.
  6. Burkman, R. T. (2002). The transdermal contraceptive patch: A new approach to hormonal contraception. International Journal of Fertility Womens’ Medicine, 47, 69–76.
  7. Chapman, R. H., Benner, J. S., Petrilla, A. A., Tierce, J. C., Collins, S. R., Battleman, D. S., et al. (2005). Predictors of adherence with antihypertensive and lipid-lowering therapy. Archives of Internal Medicine, 165, 1147–1152. · DOI · Paper page
  8. Chengappa, K. N., Parepally, H., Brar, J. S., Mullen, J., Shilling, A., & Goldstein, J. M. (2003). A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: A pilot study. Canadian Journal of Psychiatry, 48, 187–194. · DOI
  9. Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapy, 23, 1296–1310. · DOI · Paper page
  10. Dezii, C. M., Kawabata, H., & Tran, M. (2002). Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. Southern Medical Journal, 95, 68–71. · DOI
  11. Dieben, T. O., Roumen, F. J., & Apter, D. (2002). Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstetrics and Gynecology, 100, 585–593.
  12. Dittrich, R., Parker, L., Rosen, J. B., Shangold, G., Creasy, G. W., Fisher, A. C., & Ortho Evra/Evra 001 Study Group (2002). Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. American Journal of Obstetrics and Gynecology, 186, 15–20. · DOI
  13. Dolce, J. J., Crisp, C., Manzella, B., Richards, J. M., Hardin, J. M., & Bailey, W. C. (1991). Medication adherence patterns in chronic obstructive pulmonary disease. Chest, 99, 837–841. · DOI · Paper page
  14. Donnan, P. T., MacDonald, T. M., & Morris, A. D. (1996). Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: A retrospective cohort study. Diabetic Medicine, 19, 270–284.
  15. Dunbar-Jacob J., Bohachick P., Mortimer M. K., Sereika S. M., & Foley S. M. (2003). Medication adherence in persons with cardiovascular disease. Journal of Cardiovascular Nursing, 18, 209–218. · DOI
  16. Eisen, S. A., Miller, D. K., & Woodward, R. S. (1990). The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine, 150, 1881–1884. · doi:10.1001/archinte.1990.00390200073014 · Paper page
  17. Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome, 18, 117–125. · DOI · Paper page
  18. Eron, J. J., Yetzer, E. S., Ruane, P. J., et al. (2000). Efficacy, safety, and adherence with a twice daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS, 14, 671–681. · DOI
  19. Ferguson, T. F., Stewart, K. E., Funkhouser, E., Tolson, J., Westfall, A. O., & Saag, M. S. (2002). Patient-perceived barriers to antiretroviral adherence: Associations with race. AIDS Care, 14, 607–617. · DOI
  20. Flandre, P., Peytavin, G., Meiffredy, V., Saidi, Y., Descomps, D., Delagnes, M., Brun-Vezinet, F., & Roffi, F. (2002). Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antiviral Therapy, 7, 113–121. · doi:10.1177/135965350200700205
  21. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46, 93–108. · DOI · Paper page
  22. Gallo, M. F., Grimes, D. A., & Schulz, K. F. (2003). Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews, 1, CD003552. · DOI
  23. George, J., Phun, Y. T., Bailey, M. J., Kong, D. C., & Stewart, K. (2004). Development and validation of the medication regimen complexity index. The Annals of Pharmacotherapy, 38, 1369–1376. · DOI · Paper page
  24. George, J., & Shalansky, S. J. (2007). Predictors of refill non-adherence in patients with heart failure. British Journal of Clinical Pharmacology, 63, 488–493. · DOI
  25. Gerald, L. B., McClure, L. A., Harrington, K. F., Mangan, J. M., Gibson, L., Atchison, J., et al. (2007). Design of the supervised asthma therapy study: Implementing an adherence intervention in urban elementary schools. Contemporary Clinical Trials, in press.
  26. Golden, R. N., Nemeroff, C. B., McSorley, P., et al. (2002). Efficacy and tolerability of controlled-release and immediate release paroxetine in the treatment of depression. Journal of Clinical Psychiatry, 63, 577–584. · DOI
  27. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., Kaplan, A. H., & Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756–765. · DOI · Paper page
  28. Grant, R. W., Devita, N. G, Singer, D. E., & Meigs, J. B. (2003). Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care, 26, 1408–1412. · DOI · Paper page
  29. Halkitis, P. N., Parsons, J. T., Wolitski, R. J., & Remien, R. H. (2003). Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care, 15, 89–102. · DOI
  30. Hanchak, N. A., Patel, M. B., Berlin, J. A., & Strom, B. L. (1996). Patient misunderstanding of dosing instructions. Journal General Internal Medicine, 11, 325–328. · DOI
  31. Hays, H., Hagen, N., Thirlwell, M., Dhaliwal, H., Babul, N., Harsanyi, Z., & Darke, A. C. (1994). Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer, 74, 1808–1816. · doi:10.1002/1097-0142(19940915)74:6<1808::aid-cncr2820740625>3.0.co;2-y
  32. Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow prescribed treatment: Clinical applications. Journal of the American Medical Association, 288, 2880–2883. · DOI · Paper page
  33. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950. · DOI · Paper page
  34. Ickovics, J. R., & Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50, 385–391. · DOI · Paper page
  35. Iskedjian, M., Einarson, T. R., MacKeigan, L. D., Shear, N., Addis, A., Mittmann, N., & Ilersich, A. L. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis. Clinical Therapy, 24, 302–316. · DOI · Paper page
  36. Kane, S. V. (2006). Systematic review: Adherence issues in the treatment of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 23, 577–585. · DOI · Paper page
  37. Kardas, P. (2005). The DIACOM study (effect of Dosing frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes, Obesity and Metabolism, 7, 722–728. · DOI
  38. Katlama, C., Clumeck, N., Fenske, S., et al. (2001). Use of trizivir to simplify therapy in HAART-experienced patients with long-term suppression of HIV-RNA: TRIZIAL study (AZL 30002) 24-week results. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Feb. 4–8, 2001, Abstract 316.
  39. Kelloway, J. S., Wyatt, R. A., & Adlis, S. A. (1994). Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Archieves of Intern Medicine, 154, 1349–1352. · doi:10.1001/archinte.1994.00420120066007 · Paper page
  40. Kubacka, R. T., & Juhl, R. P. (1985). Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. American Journal of Hospital Pharmacy, 42, 2499–2501.
  41. Lee, J. Y., Kusek, J. W., Greene, P. G., Bernhard, S., Norris, K., Smith, D., Wilkening, B., & Wright, J. T. Jr. (1996). Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. American Journal of Hypertension, 9, 719–725. · DOI · Paper page
  42. Lee, M., Kemp, J. A., Canning, A., Egan, C., Tataronis, G., & Farraye, F. A. (1999). A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Archives of Internal Medicine, 159, 2312–2316.
  43. Mai, L., & Eng, J. (2007). Community-based elder care: A model for working with the marginally housed elderly. Care Management Journals, 8(2), 96–99. · doi:10.1891/152109807780845564
  44. Mann, E., Eliasson, O., Patel, K., & ZuWallack, R. L. (1992). A comparison of the effects on bid and qid dosing on compliance with inhaled flunisolide. Chest, 101, 496–499. · doi:10.1378/chest.101.2.496
  45. Martin, S., Wolters, P. L., Calabrese, S. K., Toledo-Tamula, M. A., Wood, L. V., Roby, G., et al. (2007). The Antiretroviral Regimen Complexity Index: A novel method of quantifying regimen complexity. Journal of Acquired Immune Deficiency Syndrome, 45, 1–10. · doi:10.1097/qai.0b013e31811ed1f1
  46. Masand, P. S. (2003). Tolerability and adherence issues in antidepressant therapy. Clinical Therapy, 25, 2289–2304. · DOI
  47. McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: The value of electronic monitoring. AIDS, 17, 1763–1767. · DOI
  48. Misra, A., & Ganda, O. P. (2007). Migration and its impact on adiposity and type 2 diabetes. Nutrition (Burbank, Los Angeles County, Calif.), 23(9), 696–708. · DOI · Paper page
  49. Molassiotis, A., Lopez-Nahas, V., Chung, W. Y., & Lam, S. W. (2003). A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care, 15, 125–135. · DOI
  50. Morley, J. S., Bridson, J., Nash, T. P., Miles, J. B., White, S., & Makin, M. K. (2003). Low-dose methadone has an analgesic effect in neuropathic pain: A double-blind randomized controlled crossover trial. Palliative Medicine, 17, 576–587. · DOI
  51. Murphy, D. A., Roberts, K. J., Martin, D. J., Marelich, W., & Hoffman, D. (2000). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patient Care and STDs, 14, 47–58. · DOI
  52. O’Shea, S. D., Taylor, N. F., & Paratz, J. D. (2007). But watch out for the weather: Factors affecting adherence to progressive resistance exercise for persons with COPD. Journal of Cardiopulmonary Rehabilitation and Prevention, 27(3), 166–174; quiz 175–176. · DOI
  53. Paes, A. H., Bakker, A., & Soe-Agnie, C. J. (1997). Impact of dosage frequency on patient compliance. Diabetes Care, 20, 1512–1517. · DOI · Paper page
  54. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30. · DOI · Paper page
  55. Peterson, A. M., Takiya, L., & Finley, R. (2003). Meta-analysis of trials of interventions to improve medication adherence. American Journal of Health System Pharmacy, 60, 657–665. · DOI · Paper page
  56. Pinter, B. (2002). Continuation and compliance of contraceptive use. European Journal of Contraception and Reproductive Health Care, 7, 178–183. · doi:10.1080/ejc.7.3.178.183
  57. Portsmouth, S. D., Osorio, J., McCormick, K., Gazzard, B. G., & Moyle, G. J. (2005). Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: A 24-week randomized trial of treatment simplification using prolonged-release capsules. HIV Medicine, 6, 185–190. · DOI
  58. Purucker, M. E., Rosebraugh, C. J., Zhou, F., & Meyer, R. J. (2003). Inhaled fluticasone propionate by diskus in the treatment of asthma: A comparison of the efficacy of the same nominal dose given either once or twice a day. Chest, 124, 1584–1593. · DOI
  59. Richter, A., Anton, S. E., Koch, P., & Dennett, S. L. (2003). The impact of reducing dose frequency on health outcomes. Clinical Therapy, 25, 2307–2335. · DOI · Paper page
  60. Rueda, S., Park-Wyllie, L. Y., Bayoumi, A. M., Tynan, A. M., Antoniou, T. A., Rourke, S. B., & Glazier, R. H. (2006). Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Systematic Review, 3, CD001442. · DOI · Paper page
  61. Sankar, A. P., Nevedal, D. C., Neufeld, S., & Luborsky, M. R. (2007). What is a missed dose? Implications for construct validity and patient adherence. AIDS Care, 19(6), 775–780. · DOI
  62. Shoptaw, S., Reback, C. J., & Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases, 21, 91–105. · DOI
  63. Sicat, B. L. (2003). Ortho Evra, a new contraceptive patch. Pharmacotherapy, 23, 472–480. · doi:10.1592/phco.23.4.472.32120
  64. Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. Journal of Acquired Immune Deficiency Syndrome, 43, S1, S23–S35. · DOI · Paper page
  65. Stone, V. E., Hogan, J. W., Schuman, P., Rompalo, A. M., Howard, A. A., Korkontzelou, C., & Smith, D. K. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndromes, 28, 124–131. · DOI
  66. Trotta, M. P., Ammassari, A., Melzi, S., Zaccarelli, M., Ladisa, N., Sighinolfi, L., Mura, M. S., d’Arminio Monforte, A., Antinori, A., & AdICoNA Study Group (2002). Treatment-related factors and highly active antiretroviral therapy adherence. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S128–131. · DOI
  67. Wilson, I. B., Tchetgen, E., & Spiegelman, D. (2001). Patterns of adherence with antiretroviral medications: An examination of between-medication differences. Journal of Acquired Immune Deficiency Syndromes, 28, 259–263. · DOI
  68. Witteveen, E., & van Ameijden, E. J. (2002). Drug users and HIV-combination therapy (HAART): Factors which impede or facilitate adherence. Substance Use and Misuse, 37, 1905–1925. · DOI
  69. Wohl, D. A., Stephenson, B. L., Golin, C. E., Kiziah, C. N., Rosen, D., Ngo B., Liu, H., & Kaplan, A. H. (2003). Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infectious Diseases, 36, 1572–1576. · doi:10.1086/375076
  70. Yiannakopoulou, E. C., Papadopulos, J. S., Cokkinos, D. V., & Mountokalakis, T. D. (2005). Adherence to antihypertensive treatment: A critical factor for blood pressure control. European Journal of Cardiovascular Prevention and Rehabilitation, 12, 243–249. · DOI

Cited by

See all 583

Metadata

Authors
Ingersoll, K. S., & Cohen, J.
Venue
Journal of Behavioral Medicine
Publisher
Springer Science and Business Media LLC
Published
2008-01-19
Volume
31
Issue
3
Pages
213-224
ISSN
  • 0160-7715 (ISSN-L)
  • 1573-3521
DOI
10.1007/s10865-007-9147-y
OpenAlex
W2028371970
Cited by
583
References
2
FWCI
16.57
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of medication regimen factors on adherence to chronic treatment: a review of literature. https://app.cochat.ai/papers/10.1007/s10865-007-9147-y
The paper
Ingersoll, K. S., & Cohen, J. (2008). The impact of medication regimen factors on adherence to chronic treatment: a review of literature. Journal of Behavioral Medicine. https://doi.org/10.1007/s10865-007-9147-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.